Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 1 CardioNet MCOT vs. LOOP Clinical Trial.

Slides:

Advertisements

Similar presentations

LifeWatch Research Services Arrhythmia Monitoring Overview

Advertisements

JCAHO EXPECTATIONS FOR PRIMARY STROKE CENTER

Managing Palpitations in Primary care Dr Ivan Benett GPwSI cardiology 12/10/2014Dr Ivan Benett GPwSI for AA meeting.

The Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Trial The Value of Remote Monitoring George H. Crossley, MD.

Some comments on the 3 papers Robert T. O’Neill Ph.D.

Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.

INTRODUCTION  Reliable EKG monitoring is the backbone of arrhythmia diagnosis and management  Accurate diagnosis (or exclusion) of arrhythmias responsible.

Personal Digital Assistants: Revolutionizing Medical Care Lauren McKenna and Dallas Warren ORF/PSY 322- H/M Interactions May 5 th, 2005.

Wireless Pervasive Health Monitoring

Arrhythmias: The Good, the Bad and the Ugly

Triage Nurse Initiation of Corticosteroids in Paediatric Asthma is Associated With Improved Emergency Department Efficiency Zemak et al Pediatrics Volume.

Very Rapid Treatment of STEMI: Utilizing Pre-Hospital ECGs to Bypass the Emergency Department Kenneth W. Baran, MD Medical Director for United Hospital’s.

TOWARD A PERSONAL HEALTH SOCIETY IN CARDIOLOGY Jocelyne Fayn and Paul Rubel IEEE TRANSACTIONS ON INFORMATION TECHNOLOGY IN BIOMEDICINE, VOL. 14, NO. 2,

 Definition: “The use of computers, the Internet, and other communication technologies to provide medical care to patients at a distance.”  Forms: 

Telemedicine Remote Cardiac Monitoring Industry Overview Gateway to Opportunities in Healthcare 1 Presented by Ghislain Vander Elst, CEO CardioLabs, Inc.

CAROTID SINUS SYNDROME Evidence review. Introduction The hypersensitive carotid sinus syndrome (CSS) is defined as syncope or presyncope resulting from.

Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?

Intervention Studies Principles of Epidemiology Lecture 10 Dona Schneider, PhD, MPH, FACE.

Utility of Post-Therapy Surveillance Scans in Diffuse Large B-Cell Lymphoma Thompson C et al. Proc ASCO 2013;Abstract 8504.

Sarah Struthers, MD March 19, 2015

Copyright © CRF Box, Ltd. All rights reserved. 1 Introduction to Electronic Data Collection Methods; Improving Data Quality and Integrity in Epidemiological.

Investigation of Possible Periodic Paralysis (P3)

Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.

First author: Sendrea Octavian-Laurentiu Coordinator: Senior Lecturer Gozar Liliana, MD, PhD.

XPECT Study Physician Presentation. XPECT Study 1 Purpose Quantify the performance of the first implantable leadless cardiac monitor (ICM) with dedicated.

Fibromyalgia Patients Reading Self-Help Journals and in Internet Self-Help Groups: Are They Different from Patients in Clinical Practice? Robert Katz 1,

Target Study Cardiac resynchronization therapy (CRT) is an established treatment for advanced heart failure symptoms, impaired LV systolic function, and.

Background  Obesity is an extremely common problem ~ 1/3 of adult Americans are obese  Patients commonly ask physicians for advice on weight loss, yet.

Wireless Cardiac Device Monitoring Presented by: Ashley D. Solomon, RN Nursing 457: Nursing Informatics Fall 2009.

Dr K N Prasad Community Medicine

ENESTnd Update: Nilotinib (NIL) vs Imatinib (IM) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and the Impact.

Monthly Journal article review: Vimmi Kang PGY 2

ICT and medicine. Objectives The uses of ICT in medicine The uses of ICT in medicine in patient records, medical equipments, internet devices…etcin patient.

1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?

Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.

PLATINUM A Prospective, Randomized, Investigation of a Novel Platinum Chromium Everolimus-Eluting Coronary Stent: The PLATINUM Trial Objective To evaluate.

Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.

HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.

The Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial ONTARGET.

SEVERAL MAJOR CAPABILITIES OF CRITICAL CARE INVIRONMENT 1.Process store and intergrate physiologic and diagnostic information from various sources. 2.Accept.

QUALCOMM Confidential Wireless Healthcare Case Study CardioNet March 9, 2006Richard Lobovsky Director, Business Development QUALCOMM, Inc.

Asthma Management and the Allergist: Better Outcomes at Lower Cost.

Your text would go here. Introduction to Glass OCT Technology Google Glass Optical Coherence Tomography (OCT) is a feature of Glass that is revolutionizing.

Multi channel ECG 10 th August Reference Article  “Multichannel ECG measurement for noninvasive identification of heart regions with changed repolarization”

: PROFI : A Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Filter Embolic Protection in Patients Undergoing Carotid Stenting Klaudija.

 2014 Diagnotes, Inc. – Confidential & Proprietary Spring Into Quality Symposium March 14, 2014.

The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.

Global Cardiac Event Ambulatory Monitors and Recorder Market Size, Share, Global Trends, Analysis, Research Report and Forecast,

Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.

Emergency Medicine Junior Teaching Programme Aberdeen Royal Infirmary Adult Syncope Evaluation in the Emergency Department Jamie Cooper Teaching 4 th March.

Serial 2-Point Ultrasonography Plus D-Dimer vs Whole-LegColor-CodedDopplerUltrasonography for Diagnosing Suspected Symptomatic Deep Vein Thrombosis A Randomized.

Cebu Normal University College of Nursing - Graduate Studies Clinical Nursing Information System A report by Carmenila S. Inso, RN Submitted to Domino.

Ventricular Arrhythmias:A General Cardiologist’s Assessment of Therapies in 2004 C.Richard Conti M.D. MACC.

R2. 최태웅 / Pf. 김진배. BACKGROUND  Ischemic stroke : leading causes of death and disability : cause remains unexplained after routine evaluation → Cryptogenic.

Steven Cantor Life Medical Technologies, Inc. Steven A. Cantor and His Efforts in Cardiovascular Disease Treatment.EECP Treatment for Patients with Angina.

Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology The EXERRT trial – “EXErcise to Regadenoson in Recovery.

Patient Enrollment Guide

Cryptogenic Stroke and AF

Conditions & Treatments Conditions Treatments Our experts cardiologist diagnose and treat patients with coronary artery disease, heart failure, valve.

Update on the Watchman Device CRT 2010 Washington, DC

Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome

Cost-effective Approaches to Diagnosing Syncope

RIDDLE-NSTEMI Trial design: Patients with NSTEMI were randomized to either immediate (within 2 hours) intervention or delayed (within 72 hours) intervention.

BRAVO-3 Trial design: Patients undergoing transfemoral TAVR were randomized in a 1:1 fashion to bivalirudin or UFH. They were followed for 30 days. Results.

NIH’S Redefinition of Clinical Trials and Using the New Human Subjects Form Chris Sylvester, M.A. Senior Grant Administrator (AO) Grants and Contracts.

ACC/SCAI – i2 Summit Late Breaking Clinical Trials March 29, 2008

The Basics of Play Therapy for Early Childhood Intervention

Pre-hospital prediction of transmural myocardial infarction and the need of acute coronary reperfusion by an artificial neural network compared to real-time.

The Power of As-Treated Analyses

Presentation transcript:

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 1 CardioNet MCOT vs. LOOP Clinical Trial

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 2 CardioNet vs. LOOP Clinical Trial Protocol Title: The Diagnosis of Cardiac Arrhythmias: A Prospective, Multi-Center, Randomized Study Comparing Mobile Cardiac Outpatient Telemetry versus Standard LOOP Event Monitoring Principal Investigator: Steven A. Rothman, Mainline Health Center Study Design: 17 center, 300 patient randomized study to compare the relative value of the CardioNet Mobile Cardiac Outpatient Telemetry (MCOT) system with a patient activated external looping event monitor (LOOP) for symptoms (palpitations, syncope and/or presyncope) thought to be due to an arrhythmia. Primary Endpoint: Confirmation or exclusion of a probable arrhythmic cause of patient’s symptoms Journal: Journal of Cardiovascular Electrophysiology, Vol. 18, Number 3, March 2007; Journal of Cardiovascular Electrophysiology Online Early doi: /j x Volume 0 Issue 0 Conclusion: MCOT provided a significantly higher yield than LOOP monitors in patients with symptoms suggestive of a significant cardiac arrhythmia

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 3 Clinical Trial Results Presenting symptoms: – Palpitations – 81% – Presyncope – 34% – Syncope – 16% Subjects (per protocol): – CardioNet – 134 patients – LOOP – 132 patients 114 subjects (43%) presented with syncope or presyncope: – CardioNet – 62 subjects – LOOP – 52 subjects

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 4 Clinical Trial Results

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 5 Clinical Trial Results

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 6 Clinical Trial Results

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 7 Clinical Trial Results

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 8 Clinical Trial Results

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 9 Clinical Trial Results

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 10 Seven More Reasons to Prescribe CardioNet Improved Patient Compliance Enables you to diagnose and treat sooner. CardioNet: 24-hour trend graphs and beat-to-beat analysis reveal any patient noncompliance.

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 11 Seven More Reasons to Prescribe CardioNet Superior Algorithm Enables you to diagnose more accurately. CardioNet: Highly sensitive and accurate. Detects by rate, rhythm, and morphology.

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 12 Seven More Reasons to Prescribe CardioNet Automatic, Mobile Transmission Improves patient compliance – greater data capture for you. CardioNet: Symptomatic and asymptomatic events are stored and transmitted automatically via landline or cellular technology, when in the home or away, requiring no patient intervention.

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 13 Seven More Reasons to Prescribe CardioNet Analysis and Response 24/7/365 by the CardioNet Center Be secure knowing trained personnel are monitoring your patients. Gives you the ability to know precisely how your patients are doing.

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 14 Seven More Reasons to Prescribe CardioNet Real-time Symptom/ECG Correlation Easy for you to compare and analyze data. CardioNet: Symptoms reported by patients are clearly defined on the CardioNet reports.

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 15 Seven More Reasons to Prescribe CardioNet Monitor Memory Storage Stores 96 hours of ECG data; no event can be lost due to memory limitations. CardioNet: Has the ability to remotely “fetch” ECG data upon physician request.

Get to the Heart of the Problem C A R D I O N E TC A R D I O N E T CardioNet, Inc. Company Proprietary 16 Seven More Reasons to Prescribe CardioNet Physician Reporting by Internet or Fax CardioNet: Patient reports delivered to you via the Internet or by fax – whichever is most convenient for you.